chr19-55602789-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153219.4(ZNF524):c.677G>A(p.Gly226Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,611,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153219.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152276Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.0000790 AC: 19AN: 240526Hom.: 0 AF XY: 0.0000454 AC XY: 6AN XY: 132196
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1458748Hom.: 0 Cov.: 89 AF XY: 0.0000110 AC XY: 8AN XY: 725802
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152276Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | The c.677G>A (p.G226E) alteration is located in exon 2 (coding exon 1) of the ZNF524 gene. This alteration results from a G to A substitution at nucleotide position 677, causing the glycine (G) at amino acid position 226 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at